Heng Mei

1.1k total citations
23 papers, 984 citations indexed

About

Heng Mei is a scholar working on Biomaterials, Biomedical Engineering and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Heng Mei has authored 23 papers receiving a total of 984 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Biomaterials, 13 papers in Biomedical Engineering and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Heng Mei's work include Nanoparticle-Based Drug Delivery (13 papers), Nanoplatforms for cancer theranostics (13 papers) and Photodynamic Therapy Research Studies (3 papers). Heng Mei is often cited by papers focused on Nanoparticle-Based Drug Delivery (13 papers), Nanoplatforms for cancer theranostics (13 papers) and Photodynamic Therapy Research Studies (3 papers). Heng Mei collaborates with scholars based in China, South Korea and United States. Heng Mei's co-authors include Bin He, Jun Cao, Shengsheng Cai, Yu Hu, Zhiqing Pang, Dennis Huang, Xinguo Jiang, Bo Zhang, Huile Gao and Ziwei Liao and has published in prestigious journals such as Blood, Biomaterials and Advanced Functional Materials.

In The Last Decade

Heng Mei

21 papers receiving 968 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heng Mei China 14 557 506 360 127 111 23 984
Alexandros Marios Sofias Germany 17 505 0.9× 447 0.9× 494 1.4× 135 1.1× 128 1.2× 32 1.2k
Huining He China 19 499 0.9× 530 1.0× 573 1.6× 124 1.0× 135 1.2× 44 1.3k
Zimiao Luo China 16 730 1.3× 498 1.0× 467 1.3× 86 0.7× 167 1.5× 20 1.2k
Tingting Lin China 12 373 0.7× 409 0.8× 467 1.3× 206 1.6× 104 0.9× 47 1.1k
Xiaoqing Ren China 15 478 0.9× 405 0.8× 463 1.3× 77 0.6× 106 1.0× 20 1.0k
Hongyue Jin China 10 459 0.8× 513 1.0× 557 1.5× 171 1.3× 118 1.1× 10 1.2k
Seungho Lim South Korea 14 444 0.8× 273 0.5× 392 1.1× 112 0.9× 75 0.7× 18 863
Vijay Sagar Madamsetty United States 17 359 0.6× 333 0.7× 464 1.3× 128 1.0× 172 1.5× 31 1.1k
Soyoung Son South Korea 17 613 1.1× 537 1.1× 451 1.3× 114 0.9× 101 0.9× 23 1.2k
Hyeyoun Chang South Korea 13 543 1.0× 366 0.7× 310 0.9× 78 0.6× 200 1.8× 17 987

Countries citing papers authored by Heng Mei

Since Specialization
Citations

This map shows the geographic impact of Heng Mei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heng Mei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heng Mei more than expected).

Fields of papers citing papers by Heng Mei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heng Mei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heng Mei. The network helps show where Heng Mei may publish in the future.

Co-authorship network of co-authors of Heng Mei

This figure shows the co-authorship network connecting the top 25 collaborators of Heng Mei. A scholar is included among the top collaborators of Heng Mei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heng Mei. Heng Mei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Tang, Yuxiang, Hang Hu, Chaohong Liu, et al.. (2024). Indocyanine green-mediated fabrication of urchin-like hydroxyethyl starch nanocarriers for enhanced drug tumor EPR and deep penetration effects. International Journal of Biological Macromolecules. 271(Pt 1). 132616–132616. 5 indexed citations
5.
Wu, Yingying, et al.. (2023). The inhibitory effect of isoliquiritigenin on human platelets in vitro. Annals of Translational Medicine. 11(6). 250–250. 4 indexed citations
6.
Lei, Lei, Shengsheng Cai, Yan Zhang, et al.. (2022). Structure Inversion‐Bridged Sequential Amino Acid Metabolism Disturbance Potentiates Photodynamic‐Evoked Immunotherapy. Advanced Functional Materials. 32(21). 42 indexed citations
7.
He, Yanmei, Jun Cao, Xiaotong Yang, et al.. (2021). A combinational chemo-immune therapy using an enzyme-sensitive nanoplatform for dual-drug delivery to specific sites by cascade targeting. Science Advances. 7(6). 123 indexed citations
8.
Mei, Heng, Shengsheng Cai, Xuequan Zhang, et al.. (2021). Fluorocarbon-driven photosensitizer assembly decodes energy conversion pathway for suppressing breast tumor. Nano Today. 41. 101305–101305. 52 indexed citations
9.
Mei, Heng, Shengsheng Cai, Dennis Huang, et al.. (2021). Carrier-free nanodrugs with efficient drug delivery and release for cancer therapy: From intrinsic physicochemical properties to external modification. Bioactive Materials. 8. 220–240. 173 indexed citations
10.
Mei, Heng, Jing Li, Shengsheng Cai, et al.. (2021). Mitochondria-acting carrier-free nanoplatform self-assembled by α-tocopheryl succinate carrying cisplatin for combinational tumor therapy. Regenerative Biomaterials. 8(4). rbab029–rbab029. 10 indexed citations
11.
Hai, Zhang, Jianqin Yan, Heng Mei, et al.. (2020). High-drug-loading capacity of redox-activated biodegradable nanoplatform for active targeted delivery of chemotherapeutic drugs. Regenerative Biomaterials. 7(4). 359–369. 10 indexed citations
12.
Cai, Shengsheng, et al.. (2019). Enzyme-triggered deshielding of nanoparticles and positive-charge mediated lysosomal escape for chemo/photo-combination therapy. Journal of Materials Chemistry B. 7(31). 4758–4762. 18 indexed citations
13.
Zhang, Bo, Ting Jiang, Kai Jin, et al.. (2017). Captopril improves tumor nanomedicine delivery by increasing tumor blood perfusion and enlarging endothelial gaps in tumor blood vessels. Cancer Letters. 410. 12–19. 36 indexed citations
14.
Zhang, Bo, Ting Jiang, Xiaojian She, et al.. (2016). Fibrin degradation by rtPA enhances the delivery of nanotherapeutics to A549 tumors in nude mice. Biomaterials. 96. 63–71. 38 indexed citations
15.
Zhang, Bo, Huafang Wang, Ziwei Liao, et al.. (2014). EGFP–EGF1-conjugated nanoparticles for targeting both neovascular and glioma cells in therapy of brain glioma. Biomaterials. 35(13). 4133–4145. 52 indexed citations
16.
Zhang, Bo, Shun Shen, Ziwei Liao, et al.. (2014). Targeting fibronectins of glioma extracellular matrix by CLT1 peptide-conjugated nanoparticles. Biomaterials. 35(13). 4088–4098. 90 indexed citations
17.
Su, Jian, et al.. (2014). Study on Dynamical Simulation of Railway Vehicle Bogie Parameters Test-Bench Electro-Hydraulic Servo System. Applied Mechanics and Materials. 644-650. 863–866. 1 indexed citations
18.
Liu, Xinjin, et al.. (2013). Numerical Studies on a Three-dimensional Flow Field in Four-Roller Compact Spinning with a Guiding Device. Fibres and Textiles in Eastern Europe. 3 indexed citations
19.
Zhang, Bo, Xiyang Sun, Heng Mei, et al.. (2013). LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma. Biomaterials. 34(36). 9171–9182. 184 indexed citations
20.
Mei, Heng, Wei Shi, Zhiqing Pang, et al.. (2010). EGFP-EGF1 protein-conjugated PEG–PLA nanoparticles for tissue factor targeted drug delivery. Biomaterials. 31(21). 5619–5626. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026